# QLESP Block for Pain Control in Robotic Partial Nephrectomy

> **NCT07704970** · NA · RECRUITING · sponsor: **Huazhong University of Science and Technology** · enrollment: 120 (estimated)

## Conditions studied

- Renal Cell Carcinoma (Kidney Cancer)
- Postoperative Pain
- Nerve Block

## Interventions

- **DRUG:** ropivacaine (local infiltration)
- **DRUG:** ropivacaine

## Key facts

- **NCT ID:** NCT07704970
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-22
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704970, "QLESP Block for Pain Control in Robotic Partial Nephrectomy". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07704970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*